examples of glp 1 receptor agonists GLP-1 GLP-1 Receptor Agonists | New
Description
DOI: 10.1001/jamanetworkopen.2022.31982
Sanofi is also dealing with the decline in insulin sales due to newer insulin products and biosimilars, which puts pressure on its pipeline
Counterfeit drugs often lack efficacy, pose health hazards, and erode brand reputation for innovator companies
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R
doi: Pirro V, Roth KD, Lin Y, et al
